Two progressive pathways of microinvasive carcinoma: low-grade luminal pathway and high-grade HER2 pathway based on high tumour-infiltrating lymphocytes

• Material Type: 博士論文
• Title: Two progressive pathways of microinvasive carcinoma: low-grade luminal pathway and high-grade HER2 pathway based on high tumour-infiltrating lymphocytes
• Author/Editor: 森田, 道
• Author Heading: 森田, 道
• Publication, Distribution, etc.: BMJ Publishing Group
• Publication Date: 2018-03-07
• Publication Date (W3CDTF): 2018-03-07
• Alternative Title: 微小浸潤癌の二つの進展経路：低異型度 ? luminal経路と高度腫瘍浸潤リンパ球に伴う高異型度 ? HER2経路
• Periodical title: Journal of Clinical Pathology
• No. or year of volume/issue: 69 10
• Volume: 69
• Issue: 10
• Pages: 890-898
• ISSN (Periodical Title): ISSN : 00219746; ISSN : 14724146
• Degree grantor/type: Nagasaki University (長崎大学)
• Date Granted: 2018-03-07
• Dissertation Number: 甲医歯薬第1016号
• Degree Type: 博士(医学)
• Text Language Code: eng
• Subject Heading: breast cancer; microinvasive carcinoma; tumor infiltrating lymphocytes; HER2
• Target Audience: 一般
• Note (General): 長崎大学学位論文 学位記番号:博(医歯薬)甲第1016号 学位授与年月日:平成30年3月7日; Author: Michi Morita, Rin Yamaguchi, Maki Tanaka, Gary M Tse, Miki Yamaguchi, Hiroko Otsuka, Naoki Kanomata, Shigeki Minami, Susumu Eguchi, Hirohisa Yano; Citation: Journal of Clinical Pathology, 69(10), pp.890-898; 2016; Nagasaki University (長崎大学), 博士(医学) (2018-03-07)
• Format (IMT): application/pdf
• Source: ISYK1016_Morita.pdf （fulltext）; https://nagasaki-u.repo.nii.ac.jp/record/2987/files/ISYK1016_Morita.pdf
• Access Restrictions: インターネット公開
• Rights (production): c 2016. Reuse of this manuscript version is permitted strictly pursuant to the terms of the CC-BY-NC-ND 4.0 license: http://creativecommons.org/licenses/by-nc-nd/4.0/
• Related Material (URI): HDL; http://hdl.handle.net/10069/38058
• Related Material (DOI): 10.1136/jclinpath-2015-203506
• Data Provider (Database): 国立情報学研究所 : 学術機関リポジトリデータベース（IRDB）（機関リポジトリ）; https://irdb.nii.ac.jp
• Original Data Provider (Database): 長崎大学 : 長崎大学学術研究成果リポジトリ

• Summary, etc.: Aims: While cancer immunity is involved in tumour progression from the very early stage, no detailed study has been reported on the relationship betwe...